Psychology of Addictive Behaviors, published by the Educational Publishing Foundation of the American Psychological Association, is a distinguished peer-reviewed journal dedicated to advancing the understanding of addiction through rigorous psychological research. With an impressive impact factor and a reputation for excellence, this journal holds a prestigious Q1 quartile ranking in Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health as of 2023. Since its inception in 1993, it has provided a vital platform for the dissemination of high-quality studies, fostering collaboration and knowledge exchange amidst researchers, clinicians, and students in the mental health arena. The journal is particularly noted for its comprehensive coverage of diverse topics related to addictive behaviors, thereby contributing significantly to the field's evidence base and clinical practices. Although currently not open access, its commitment to scholarly excellence ensures that subscribers benefit from invaluable insights into the complexities of addiction. With the culmination of research spanning from 1993 to 2024, Psychology of Addictive Behaviors stands as a cornerstone for those striving to understand and combat the challenges of addiction.

The JOURNAL OF CLINICAL PSYCHIATRY is a premier publication dedicated to advancing the understanding and treatment of psychiatric disorders. Established in 1978 and published by Physicians Postgraduate Press, this esteemed journal provides a vital platform for researchers, clinicians, and mental health professionals to share innovative findings and evidence-based practices in psychiatry. With an impressive impact factor and recognized as a Q1 journal in both Medicine (miscellaneous) and Psychiatry and Mental Health, the journal ranks among the top in its field, sitting at 96th out of 567 in Scopus rankings, placing it in the 83rd percentile. The journal's commitment to high-quality, peer-reviewed articles facilitates the dissemination of knowledge crucial for advancing clinical practices and improving patient outcomes. Access to its latest research is offered through institutional subscriptions, making it an essential resource for anyone involved in the mental health sector, from seasoned practitioners to aspiring students.

Suchttherapie, an esteemed journal published by GEORG THIEME VERLAG KG, serves as a critical platform within the fields of Applied Psychology and Psychiatry and Mental Health. Established in 2000 and continuing through 2024, this journal is committed to advancing the understanding and treatment of addiction and related psychological issues. Although it currently stands in the Q4 Quartile ranking and is categorized as low percentile in both Scopus Ranks and impact metrics, its significance lies in its dedication to disseminating cutting-edge research and clinical findings that contribute to the evolving landscape of therapeutic practices. Published in Germany, the journal facilitates unlimited access to the vital discourse surrounding mental health and addiction treatment, making it a valuable resource for researchers, professionals, and students alike seeking to enhance their knowledge and skills in this important area of study. As the field continues to grow, Suchttherapie plays a pivotal role in bridging practice with academic rigor, ensuring that readers remain informed on the latest methodologies and insights.

SUBSTANCE USE & MISUSE, published by Taylor & Francis Inc, is an esteemed academic journal dedicated to the multifaceted study of substance use and its implications on health and society. With a notable impact factor and categorized in the Q2 quartile across multiple fields—including Health (Social Science), Medicine (Miscellaneous), Psychiatry and Mental Health, as well as Public Health—this journal serves as an essential platform for researchers, professionals, and students alike. Spanning from 1966 to 2024, it provides a rich archive of peer-reviewed articles that explore current trends, innovative research, and evidence-based practices in the management and understanding of substance use. The journal offers various access options, catering to the diverse needs of its audience and affirming its commitment to fostering scholarly discourse in the United Kingdom and beyond. By engaging with this journal, readers can enhance their understanding of the complexities surrounding substance use, making it a crucial resource for advancing knowledge and informing policy in this critical area of public health.

Adicciones is a prominent academic journal dedicated to the fields of Medicine and Psychiatry, focusing on the multi-faceted issues surrounding addiction and substance use. Published by SOCIDROGALCOHOL in Spain, this journal has been a critical resource for researchers, clinicians, and students since its inception in 1994, with a commitment to advancing knowledge in addiction science for the benefit of public health. With an impressive impact factor that places it in the Q3 category of both Medicine (Miscellaneous) and Psychiatry and Mental Health according to 2023 rankings, Adicciones is recognized for its high-quality peer-reviewed articles that contribute to the ongoing dialogue in these vital fields. Although not currently an open-access journal, it provides valuable subscription-based access to its extensive repository of research findings and reviews, fostering a deeper understanding of the complex dynamics of addiction. The journal's continued relevance is underscored by its convergence into 2024, promising ongoing contributions that inspire new ideas and practices to combat addiction.

DRUG AND ALCOHOL REVIEW, published by Wiley, is a leading journal dedicated to advancing the scholarship in the fields of drug and alcohol research. Since its inception in 1989, this esteemed publication has provided a critical platform for the dissemination of innovative research findings, reviews, and theoretical papers, addressing pressing issues in substance use and addiction. With an impact factor that places it in the Q1 category in both Health (social science) and Medicine (miscellaneous), it ranks #78 out of 371 in the Scopus index for Health and #115 out of 398 in Medicine, reflecting its significant influence and high citation rates among scholars. The journal is committed to fostering a multidisciplinary approach, integrating perspectives from psychology, sociology, public health, and medicine, to inform policy and practice. Accessible to researchers and practitioners alike, *DRUG AND ALCOHOL REVIEW* serves as an essential resource for anyone invested in understanding and addressing the complexities of drug and alcohol use in society.

Drug and Alcohol Dependence is a premier journal published by Elsevier Ireland Ltd, dedicated to the rigorous exploration and analysis of substance use disorders, including drug and alcohol dependencies. With its established history since 1975 and a remarkable convergence of research extending to 2024, the journal holds a prestigious position within the academic community, evidenced by its Q1 ranking in multiple categories, including Pharmacology, Psychiatry and Mental Health, and Toxicology for 2023. It ranks impressively among its peers, underscored by Scopus rankings of #46, #99, and #27 in key fields related to medical pharmacology and toxicology. As a non-open access title, it caters to a global readership of researchers, professionals, and students, providing them with peer-reviewed insights into critical developments and innovative methodologies in the field. The journal’s commitment to advancing knowledge and understanding of drug and alcohol dependence is essential for addressing the global challenges posed by substance use, making it a valuable resource for all stakeholders in public health and clinical practice.

Alcoholism Treatment Quarterly is a reputable journal dedicated to advancing the understanding of alcohol use disorders and their treatment. Published by Routledge Journals, Taylor & Francis Ltd, this journal has established itself as an essential resource within the fields of Medicine and Psychiatry and Mental Health, evidenced by its placement in the Q3 category for both disciplines in 2023. With a comprehensive scope covering the multifaceted aspects of alcoholism treatment, the journal serves as a vital platform for researchers, clinicians, and students to share and access high-quality, peer-reviewed articles. Although it is not an open-access journal, it is widely recognized for its contribution to the field, having been in continuous publication since 1984 and looking forward to its 40th anniversary in 2024. The journal aims to promote evidence-based practices and foster discourse on innovative treatment methods and research trends, making it an indispensable asset for anyone involved in the prevention and treatment of alcohol-related issues.

Welcome to the International Journal of Alcohol and Drug Research, an esteemed publication dedicated to advancing the understanding and research surrounding alcohol and drug-related issues. Published by Ohio State University, College of Social Work, this journal serves as a vital resource for professionals and scholars engaged in social sciences, public health, and epidemiological studies. Established as an Open Access journal since 2012, it ensures that valuable research findings are readily accessible to all, promoting awareness and disseminating knowledge critical in the fight against substance abuse. With a commendable impact in the field, the journal occupies a notable position in Scopus rankings, showcasing its contribution to social health, public health, and epidemiology. Covering an extensive scope with a commitment to rigorous research, the journal aims to foster collaboration between researchers, policymakers, and practitioners, ultimately driving innovative solutions and best practices in the realm of alcohol and drug research.

Schizophrenia, published by NATURE PORTFOLIO, is a pioneering open-access journal established in 2022, dedicated to advancing the scientific understanding of schizophrenia and its associated disorders. With its commitment to disseminating high-quality research without barriers, this journal aims to provide a platform for innovative studies, reviews, and meta-analyses that enhance clinical practices and therapeutic approaches. The journal is strategically located in Berlin, Germany, a hub for mental health research and innovation. By facilitating open exchange among researchers, professionals, and students, Schizophrenia aspires to be at the forefront of the global discourse on psychiatric disorders, driving forward critical advancements that can translate into improved patient care and outcomes. With a focus on promoting the latest findings in epidemiology, neurobiology, pharmacology, and psychosocial interventions, this journal is poised to become an essential resource for scholars and practitioners alike, eager to make significant contributions to the field.